Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Canella

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Proteomics|August 29, 2013
Characterization of multiple myeloma vesicles by label-free relative quantitationSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2022
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation TherapyJihong Xu, Pei-Jung Wu, Tzung-Huei Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant GliomasAlessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Molecular Cancer Therapeutics|January 27, 2016
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple MyelomaAndrew Stiff, Enrico Caserta, Douglas W Sborov, et al.
Journal of Proteomics|January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markersSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Leukemia & Lymphoma|March 9, 2017
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomasDouglas W Sborov, Alessandro Canella, Erinn M Hade, et al.
Cell Reports|March 5, 2023
Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of gliomaSakthi Rajendran, Yang Hu, Alessandro Canella, et al.
Haematologica|October 15, 2020
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphomaYoussef Youssef, Vrajesh Karkhanis, Wing Keung Chan, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Proteomics|August 29, 2013
Characterization of multiple myeloma vesicles by label-free relative quantitationSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2022
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation TherapyJihong Xu, Pei-Jung Wu, Tzung-Huei Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant GliomasAlessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Molecular Cancer Therapeutics|January 27, 2016
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple MyelomaAndrew Stiff, Enrico Caserta, Douglas W Sborov, et al.
Journal of Proteomics|January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markersSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Leukemia & Lymphoma|March 9, 2017
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomasDouglas W Sborov, Alessandro Canella, Erinn M Hade, et al.
Cell Reports|March 5, 2023
Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of gliomaSakthi Rajendran, Yang Hu, Alessandro Canella, et al.
Haematologica|October 15, 2020
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphomaYoussef Youssef, Vrajesh Karkhanis, Wing Keung Chan, et al.
Pageof 4